Previous Article | Next Article ![]()
Journal of Virology, July 2000, p. 6459-6468, Vol. 74, No. 14
Department of Microbiology and Immunology,
The University of Texas Medical Branch at Galveston, Galveston,
Texas 77555-1019,1 and Department of
Medicine, The University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina 275142
Received 13 January 2000/Accepted 24 April 2000
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a cellular enzyme
involved in glycolysis, binds specifically to several viral RNAs, but
the functional significance of this interaction is uncertain. Both
GAPDH and polypyrimidine tract binding protein (PTB) bind to
overlapping sites in stem-loop IIIa of the internal ribosome entry site
(IRES) of Hepatitis A virus (HAV), a picornavirus. Since
the binding of GAPDH destabilizes the RNA secondary structure, we
reasoned that GAPDH may suppress the ability of the IRES to direct
cap-independent translation, making its effects antagonistic to the
translation-enhancing activity of PTB (D. E. Schultz, C. C. Hardin, and S. M. Lemon, J. Biol. Chem. 271:14134-14142,
1996). To test this hypothesis, we constructed plasmids containing a dicistronic transcriptional unit in which the HAV IRES was placed between an upstream GAPDH-coding sequence and a downstream
Renilla luciferase (RLuc) sequence. Transfection with this
plasmid results in overexpression of GAPDH and in RLuc production as a
measure of IRES activity. RLuc activity was compared with that from a control, null-expression plasmid that was identical except for a
frameshift mutation within the 5' GAPDH coding sequence. In transfection experiments, GAPDH overexpression significantly suppressed HAV IRES activity in BSC-1 and FRhK-4 cells but not in Huh-7 cells, which have a significantly greater cytoplasmic abundance of PTB. GAPDH
suppression of HAV translation was greater with the wild-type HAV IRES
than with the IRES from a cell culture-adapted virus (HM175/P16) that
has reproducibly higher basal translational activity in BSC-1 cells.
Stem-loop IIIa RNA from the latter IRES had significantly lower
affinity for GAPDH in filter binding experiments. Thus, the binding of
GAPDH to the IRES of HAV suppresses cap-independent viral translation
in vivo in African green monkey kidney cells. The enhanced replication
capacity of cell culture-adapted HAV in such cells may be due in part
to reduced affinity of the viral IRES for GAPDH.
Hepatitis A virus (HAV)
is a plus-strand RNA virus that is classified within the genus
Hepatovirus of the family Picornaviridae. The
genomic RNA of HAV contains a single long open reading frame encoding a
polyprotein which is proteolytically processed by a virus-encoded
proteinase (27). Like other picornavirus RNAs, it has a
relatively lengthy 5'-terminal nontranslated RNA segment (5'NTR) and a
shorter 3'NTR with a 3' terminal poly(A) tail. As in all
picornaviruses, the 5'NTR of HAV forms a highly ordered RNA structural
element (the internal ribosome entry site [IRES]) that is responsible
for directing the cap-independent translation of the polyprotein
(5, 23, 32). This occurs by a unique mechanism that involves
internal entry of the ribosome on the RNA hundreds of bases downstream
of the 5' end and is absolutely dependent on the secondary and probably
the tertiary structure of the 5'NTR. Although HAV can be propagated in
conventional cell culture systems, the replication of wild-type (wt)
virus is slow and leads to persistent infection in most cases without a
cytopathic effect (1, 9, 35). However, cell culture
adaptation occurs as the result of continued passage of virus
(7, 19, 24). Generally, it is accompanied by more efficient
replication and increased yields of virus. Several cell culture-adapted
HAV variants are attenuated for their ability to induce liver injury in
primates, although cell culture adaptation and attenuation are distinct phenotypes (29, 40, 42).
The genomes of several cell culture-adapted HAV strains have been
completely sequenced (7, 18, 24). One of these cell culture-adapted viruses, HM175/P16, differs from its wt parent, HM175/wt, by only 19 nucleotide (nt) substitutions scattered throughout the entire genome (24). In general, mutations within the P2 region of the genome (nonstructural proteins) and the 5'NTR of cell
culture-adapted viruses are important in enhancing the capacity of
these viruses to replicate in cultured primate cells (11, 13,
15). In particular, mutations within the 5'NTR of HM175/P16 (at
nt 152, 203 to 204, and 687) confer cell-type-specific enhancement in
viral translation and replication (10, 11, 37). A number of
studies suggest that efficient translation by IRES elements requires
not only canonical translation initiation factors but also noncanonical
host factors (2-4, 17, 20, 22, 28, 31). Therefore, it is
likely that these 5'NTR mutations enhance translation by altering the
affinity of the RNA for cellular proteins that either positively or
negatively influence the activity of the IRES.
In previous studies, we identified cellular proteins of 30, 39, 57, and
110 kDa (p30, p39, p57, and p110) which interact specifically with RNA
segments within the HAV IRES (6). p39 was the dominant RNA
binding protein present in the ribosomal salt wash fraction (RSW) of
HAV-permissive BSC-1 cells (African green monkey kidney cells) and
FrhK-4 cells (fetal rhesus kidney cells). In contrast, p57 rather than
p39 was the dominant RNA binding protein in rabbit reticulocyte lysates
as well as RSW prepared from HeLa cells and Huh-7 (human hepatocellular
carcinoma) cells (6; K. H. Chang, W. Klymstra,
and S. M. Lemon, unpublished data). p57 was shown to be
polypyrimidine tract binding protein (PTB), since it reacted with
anti-PTB antibody in an immunoblot analysis (6), while the
p39 protein was subsequently purified and identified as the cellular
glycolytic enzyme, glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(36). GAPDH and PTB compete with each other for binding to
overlapping sites on this RNA segment, which forms the 5'-most RNA
structure in the HAV IRES (5).
GAPDH has generally been considered to be a housekeeping protein
involved mainly in glycolysis, but a number of recent studies indicate
that it is multifunctional, possibly also playing roles in endocytosis,
DNA replication, DNA repair, and RNA transport and/or translation
(39). GAPDH specifically binds several cellular RNAs
including the AU-rich 3'NTR of human lymphokine mRNA, as well as human
tRNA (30, 38). In addition, after our demonstration of the
specific binding of GAPDH to the 5'NTR of HAV, the enzyme was shown to
bind specifically to 3'NTR sequences of human parainfluenza virus and
hepatitis C virus as well as the RNA pregenome of hepatitis B virus
(12, 34, 45). All of these RNAs appear to bind to GAPDH
within the NAD+ binding groove of the enzyme (30,
36). Using circular dichroism spectropolarimetry, we found that
the binding of GAPDH to stem-loop IIIa RNA of HAV resulted in
significant destabilization of RNA secondary structure, suggesting that
this interaction would be detrimental to IRES-directed translation
(36). However, the functional impact of the binding of GAPDH
to the HAV IRES has been difficult to demonstrate due to the ubiquitous
nature and high constitutive expression levels of the enzyme.
Stem-loop IIIa of the cell culture-adapted HM175/P16 virus contains a
2-nt UU deletion within a 5-nt oligo(U) tract in the wt virus (nt 200 to 204), which contributes to both the enhanced IRES activity and
greater replication capacity that characterizes this virus in BSC-1
cells (11, 37). GAPDH preferentially binds U-rich segments
of RNA (31, 37), making it likely that this mutation reduces
the affinity of this RNA segment for GAPDH. Since GAPDH is the dominant
protein in lysates of BSC-1 cells that is bound by this stem-loop of
the IRES (36), we have reasoned that this mutation may be
selected during the adaptation of the virus to growth in BSC-1 cells
because it protects the IRES against the structure-destabilizing
effects of GAPDH and thus promotes both cap-independent translation
and, secondarily, viral replication.
Here, we report experiments that provide insight into how the binding
of GAPDH to HAV RNA influences IRES function and how this phenomenon
might relate to mutations that are selected for within the IRES during
the adaptation of HAV to growth in cultured cells. We constructed
plasmids containing a dicistronic transcriptional unit in which the HAV
IRES was placed between an upstream GAPDH-coding sequence and
downstream Renilla luciferase (RLuc) sequence. Transfection with this plasmid results in overexpression of GAPDH and in RLuc production as a measure of IRES activity. As a control, cells were
transfected in parallel with a null-expression plasmid that was
identical except for a frameshift mutation within the 5' GAPDH coding
sequence. The results of these experiments indicate that GAPDH
overexpression significantly suppresses the ability of the HAV 5'NTR to
direct cap-independent translation in transfected cells. We also
demonstrate that the mutation at nt 203 to 204 in the cell
culture-adapted virus specifically reduces the affinity of stem-loop
IIIa for GAPDH, supporting the hypothesis that this mutation was
selected because it reduces the negative impact of GAPDH on
IRES-dependent translation and viral replication.
Plasmids.
pLuc-wt-RLuc and pLuc-P16-RLuc are plasmids with
dicistronic T7 transcriptional units under control of a T7 promoter
containing the firefly luciferase (FLuc) coding sequence in the first
cistron, followed by the 5' NTRs of wt HAV or cell culture-adapted
HM175/P16 virus fused to the RLuc sequence in the second cistron. These were constructed by digesting pLUC-wt-CAT and pLUC-HAV-CAT
(37) with XbaI and NotI and inserting
a PCR-derived RLuc coding sequence originating from pRLHL
(21) in lieu of the chloramphenicol acetyltransferase (CAT)
gene. pPTB-wt-RLuc and pPTB-P16-RLuc contain a similar dicistronic transcriptional unit under the control of the same CMV/T7 promoter but
with the PTB coding sequence in the first cistron. To construct these,
the wt-RLuc and P16-RLuc sequences from pLuc-wt-RLuc and pLuc-P16-RLuc
were cloned into HindIII and NotI sites
downstream of the PTB coding sequence in pPwt/AC (17).
pfsPTB-wt-RLuc and pfsPTB-P16-RLuc are identical to these constructs
except for a frameshift mutation at codon 87 of the PTB sequence, and
they were constructed in a similar fashion using p
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Functional Significance of the Interaction of
Hepatitis A Virus RNA with Glyceraldehyde 3-Phosphate Dehydrogenase
(GAPDH): Opposing Effects of GAPDH and Polypyrimidine Tract Binding
Protein on Internal Ribosome Entry Site Function
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
87-531/AC in lieu of pPwt/AC. pPTB and pfsPTB are monocistronic plasmids expressing the
wt and mutated PTB sequences, respectively, under control of the CMV/T7
promoter. These were generated by inserting PTB and fsPTB sequences
excised by partial HindIII digestion into the
HindIII site of the mammalian expression vector pRc/CMV (InVitrogen).
) (Promega) to
construct pGEM-GAPDH. A deletion-frameshift mutation was created
following codon 8 of the GAPDH sequence by HincII-BstEII digestion (removing nt 25 to 56 of
the GAPDH sequence) followed by blunt ending with mung bean nuclease
prior to religation to create pGEM-fsGAPDH. pGAPDH-wt-RLuc,
pGAPDH-P16-RLuc, pfsGAPDH-wt-RLuc, and pfsGAPDH-P16-RLuc are
dicistronic constructs containing these wt and mutated GAPDH sequences
under control of the CMV/T7 promoter upstream of the HAV IRES (wild
type or P16) and RLuc sequence in the second cistron. These were
constructed by replacing the PTB sequence of pPTB-wt-RLuc and
pPTB-P16-RLuc with a fragment containing the appropriate GAPDH coding
sequences excised from pGEM-GAPDH and pGEM-fsGAPDH by partial
HindIII digestion. Monocistronic variants of these
constructs, pGAPDH and pfsGAPDH, were generated by NotI
digestion of pGAPDH-wt-RLuc and pfsGAPDH-wt-RLuc followed by religation
leading to the removal of the wt-RLuc sequence. The mutations created
within the GAPDH and PTB sequences were confirmed by DNA sequence analysis.
Cells. The BSC-1 cells used in these experiments were obtained from David Anderson (MacFarlane-Burnett Centre, Melbourne, Australia) because they proved more readily transfectable than BSC-1 cells that had been obtained directly from the American Type Culture Collection. BSC-1 cells were grown in minimal essential medium supplemented with 10% fetal bovine serum and antibiotics. FRhK-4 and Huh-7 cells (37) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics.
In vitro translation. In vitro translation reactions were carried out using the TNT Quick Coupled Transcription-Translation system (Promega). Briefly, 1 µg of the plasmid DNA and 2 µl of [35S]methionine (1,000 Ci/mmol at 10 mCi/ml) were added to each 50-µl reaction mix, which was then incubated at 30°C for 90 min. Translated products were analyzed either by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by autoradiography or PhosphorImager (Molecular Dynamics) analysis or by an assay for RLuc enzymatic activity (see below).
DNA transfections and reporter gene assays. DNA transfections were carried out using FuGENE 6 transfection reagent (Boehringer Mannheim) under conditions recommended by the manufacturer. About 2 × 105 cells in 2 ml of medium were seeded into each well of a six-well plate 1 day prior to transfection. For each transfection, 2 µg of DNA was mixed with 6 µl of FuGENE reagent diluted with 94 µl of OptiMEM (Gibco-BRL) and incubated for 15 min at room temperature. The DNA-FuGENE complex was then added to cells directly. At 24 to 48 h following transfection, the cells were harvested and the reporter protein activity was assayed. RLuc activity was assayed using the Dual-Luciferase reporter assay system (Promega). Briefly, cells were washed twice with phosphate-buffered saline, 500 µl of passive lysis buffer (provided by the manufacturer) was added to each well, and the culture plates were placed at room temperature for 30 min prior to collection of the lysate. A 20-µl aliquot of the lysate was assayed for RLuc activity, with the luminescent signal read using a TD-20/20 luminometer (Turner Designs, Inc.).
Northern analysis. Total RNA was extracted from BSC-1 cells 48 h posttransfection using RNAqueous (Ambion, Austin, Tex.) as recommended by the manufacturer. The poly(A)+ RNA fraction was purified on Oligotex spin columns (Oligotex mRNA; Qiagen), separated by electrophoresis in a formaldehyde-agarose gel, and blotted onto a BrightStar-Plus nylon membrane (NothernMax; Ambion). The membrane was subsequently hybridized with a GAPDH-specific probe (nt 570 to 980), which was labeled using BrightStar psorlen-biotin nonisotopic labeling kit (Ambion) reagents. The hybridized products were detected using BrightStar Biodetect nonisotopic detection kit (Ambion) reagents after exposure to film (Kodak).
Cell fractionation and immunoblot analysis. BSC-1, FRhK-4, and Huh-7 cells were transfected with the monocistronic plasmids pGAPDH, pfsGAPDH, pPTB, or pfsPTB, as described above. At 48 h following transfection, cells were removed with a cell scraper and collected by centrifugation at 500 × g. Cell pellets were resuspended in NP-40 lysis buffer (10 mM Tris [pH 7.4], 10 mM NaCl, 3 mM MgCl2, 0.5% [vol/vol] NP-40), vortexed for 10 s, and kept on ice for 10 min. After separation of the nuclei by centrifugation at 500 × g, the supernatant fluid was collected as the cytoplasmic fraction. The nuclear pellet was washed in NP-40 lysis buffer once and centrifuged at 500 × g. The pelleted fraction was used in subsequent analyses.
For immunoblot analysis of transfected cells, 10 µg of the cytoplasmic extract and corresponding nuclear fraction were separated by SDS-PAGE (12.5% polyacrylamide). Following electrotransfer to polyvinylidene difluoride membranes at 100 V for 2 h, membranes were blocked with 5% skim milk in 0.1% Tween in phosphate-buffered saline for 1 h. Following two washes with the same buffer, membranes were probed with either monoclonal anti-GAPDH antibody (Bio Design International) or polyclonal anti-PTB antibody (Intronn LLC) at 1 or 3.2 µg/ml, respectively, for 1 h. The membranes were washed twice and incubated for 40 min with horseradish peroxidase-conjugated secondary antibodies to mouse (anti-GAPDH) or rabbit (anti-PTB) immunoglobulin G. After the membrane was washed thoroughly, proteins were visualized with an enhanced chemiluminescence reagent kit (Amersham International Plc.) as recommended by the manufacturer.GAPDH and PTB proteins.
Human GAPDH was purchased from
Sigma. For the preparation of PTB, Escherichia coli strain
BL21(DE3) was transformed with p(His)6-PTB and the
recombinant protein was induced by the addition of 250 µM
isopropyl-
-D-thiogalactopyranoside (IPTG) for 2.5 h
at 30°C. After being harvested, cells were resuspended in a buffer
containing 20 mM HEPES (pH 7.9), 0.5 M NaCl, 10% glycerol, 0.2 mM
phenylmethylsulfonyl fluoride and lysed at 1,000 lb/in2 in
a French press. Lysates were centrifuged at 40,000 rpm for 90 min in a
Ti70 rotor (Beckman) to remove membranes. The supernatant fraction was
then applied to an Ni-nitrilotriacetic acid resin and subjected to
imidazole elution. Purified recombinant PTB was concentrated 40-fold in
a buffer containing 80 mM sodium phosphate (pH 7.7), 0.1 mM EDTA, and
10% glycerol. Proteins were kept frozen at
80°C until use.
Stem-loop IIIa RNA probes. pT7-sIIIa(P16) and pT7-sIIIa(wt) were digested with XbaI, and RNA was transcribed in a runoff reaction with T7 RNA polymerase (Promega). RNA was radiolabeled by the incorporation of [32P]UTP (8,000 Ci/mmol; Amersham). Following digestion with RNase-free RQ1 DNase, the RNA probe was purified on a G-50 column (Boehringer Mannheim).
Filter binding assay.
A filter binding assay, measuring the
affinity of the stem-loop IIIa RNA probes for GAPDH and PTB, was
developed from similar assays described by Wong and Lohman
(44). Briefly, the binding reaction was carried out in
binding buffer A (20 mM HEPES [pH 7.6], 10 mM KCl, 10% glycerol, 0.1 mM EDTA, 0.2 mM dithiothreitol, 100 µg of bovine serum albumin per
ml) with 10
11 M 32P-labeled HAV stem-loop
IIIa RNA (wild type [wt] or P16) and 10
7 to
10
10 M human GAPDH or PTB. The binding-reaction mixtures
were incubated for 15 min at room temperature and then passed through a
nitrocellulose filter that preferentially retains protein and
protein-RNA complexes and a Hybond N+ filter that retains
RNA, previously equilibrated in binding buffer B (binding buffer A
without bovine serum albumin). The filters were washed with 50 µl of
ice-cold binding buffer B, dried, and exposed to X-ray film or
subjected to PhosphorImager analysis. Dissociation constants for GAPDH
(tetramer form) and PTB (dimer form) were calculated as described by
Weeks and Cech (43).
| |
RESULTS |
|---|
|
|
|---|
Dicistronic IRES reporter constructs that overexpress GAPDH or
PTB.
To assess the potential functional significance of the
binding of GAPDH to the HAV IRES, we constructed a series of plasmids containing dicistronic transcriptional units under control of the
CMV/T7 composite promoter, as depicted in Fig.
1A (pGAPDH-wt-RL and pGAPDH-P16-RL).
GAPDH is translated in a cap-dependent manner from the 5'-most open
reading frame of the transcripts produced in cells transfected with
these plasmids, while RLuc is translated from the downstream reading
frame, under control of the HAV IRES, which is placed within the
intercistronic space. The proximity of the GAPDH reading frame to the
RNA segment that comprises the IRES leads to the synthesis of the
protein within the immediate microenvironment of the IRES. This
enhances the likelihood that a functional effect of the enzyme on IRES
activity would be detected in transient-expression assays. The two
dicistronic GAPDH expression vectors (pGAPDH-wt-RL and pGAPDH-P16-RL
[Fig. 1A]) contained either the wt or cell culture-adapted HM175/P16
IRES elements, allowing a comparison of the effects of GAPDH
overexpression from the upstream reading frame on these two
functionally different IRES sequences. As controls for
transient-expression experiments, we created two related plasmids, each
containing a frameshift mutation following codon 8 of the GAPDH
coding sequence (pfsGAPDH-wt-RL and pfsGAPDH-P16-RL) (Fig. 1A). The
mutations in these GAPDH "null mutants" ablate the expression
of GAPDH but should have little impact on the higher-order structures
of the dicistronic RNAs. Using a similar approach but a different
reporter protein, we have recently shown that PTB overexpression in
BSC-1 cells stimulates cap-independent translation directed by the cell
culture-adapted HM175/P16 virus IRES (17). Thus, as a
positive control for these experiments, we constructed similar
dicistronic reporter plasmids in which the PTB sequence or a frameshift
deletion PTB-null mutant replaced the upstream GAPDH reading frame
(Fig. 1A). We also constructed monocistronic plasmids expressing only
the GAPDH or PTB protein or their frameshift null mutants (Fig. 1B).
|
|
GAPDH and PTB have opposing effects on HAV IRES-dependent
translation in BSC-1 cells.
To determine whether GAPDH
overexpression would have any effect on IRES-dependent translation in
vivo, we transfected BSC-1 cells with the plasmids shown in Fig. 1A.
The quantity of RLuc expressed by cells transfected with plasmids
containing the wt HAV IRES, pGAPDH-wt-RL, was approximately twofold
lower than that expressed by cells transfected with the cognate null
mutant, pfsGAPDH-wt-RL (Fig. 3A, compare
bars 1 and 2). The suppression of translation was reproducible and
highly statistically significant in replicate experiments (relative to
the null mutant, mean translation and standard deviation [SD] = 46.7% ± 4.2%; P < 0.001 by the t test). Thus, the overexpression of GAPDH has a negative effect on IRES function in vivo, consistent with the previously noted
helix-destabilizing activity of the enzyme in vitro (36). A
lesser suppressive effect of GAPDH was evident when cells were
transfected with plasmids containing the cell culture-adapted HM175/P16
IRES. However, there was still a significant reduction in IRES activity
when GAPDH was expressed (relative to the null mutant, mean translation
and SD = 71.3% ± 6.4%; P = 0.02 by the
t test) (Fig. 3A, compare bars 3 and 4). Consistent with the
greater translational activity of the cell culture-adapted IRES in
BSC-1 cells (37), the production of RLuc was significantly
greater than in cells transfected with plasmids containing the wt IRES
(Fig. 3A, compare bars 1 and 3 and compare bars 2 and 4). These
differences, which were also highly statistically significant in repeat
experiments, are in good agreement with results of previous studies
(37). Since GAPDH is a very abundant cellular protein, the
lesser effect of GAPDH overexpression on the cell culture-adapted IRES
raises the possibility that its greater basal translational
activity in BSC-1 cells may reflect a reduced susceptibility to
suppression by endogenous GAPDH, compared with the wt IRES.
|
|
Effect of GAPDH on HAV IRES activity in other cell types.
The
experiments summarized in Fig. 3 were carried out with BSC-1 cells,
which are derived from African green monkey kidney cells. This is the
cell type used for adaptation of the HM175/P16 virus to growth in cell
culture, and these cells are maximally permissive for the replication
of this virus. To compare the effects of GAPDH and PTB on IRES activity
in other cell types, we carried out similar experiments with FRhK-4 and
Huh-7 cells. These cell lines are derived from fetal rhesus kidney and
human hepatocellular carcinoma, respectively, and both are also
permissive for replication of the HM175/P16 virus. The results of these
experiments are depicted in Fig. 5, which
shows the relative activity of RLuc expressed from each of the
dicistronic transcripts in relation to the RLuc activity expressed from
the cognate frameshift mutant in each cell type. In this analysis, a
relative RLuc activity greater than 1.0 indicates that overexpression
of the protein encoded by the upstream cistron (PTB or GAPDH) resulted
in a positive effect on translation while a value less than 1.0 indicates translational suppression. As in BSC-1 cells, GAPDH
overexpression reduced translation directed by the wt IRES by slightly
more than 50% in FRhK-4 cells but had no effect on translation by this
IRES in Huh-7 cells (Fig. 5A). On the other hand, PTB expression
enhanced translation directed by the wt IRES in both Huh-7 cells and
FRhK-4 cells but the extent of enhancement in each cell line was
substantially less than in BSC-1 cells (Fig. 5B). The results with
Huh-7 cells may reflect a greater abundance of PTB within the cytoplasm
of these cells (see below). This could potentially mask the impact of
PTB overexpression on IRES activity and could reduce (through
competition) the negative effect of GAPDH on IRES activity (see
Discussion).
|
Immunoblot detection of GAPDH and PTB in transfected cells.
Because of the differences we observed in the effects of GAPDH and PTB
overexpression on IRES activities in these three cell lines, we sought
to determine the basal abundance and intracellular distribution of
these proteins in these cells, as well as the degree of GAPDH and PTB
overexpression in transfected cells. This was accomplished by an
immunoblot analysis of nuclear and cytoplasmic cell fractions from
cells that had been transfected with the monocistronic plasmids shown
in Fig. 1B that encode either GAPDH (pGAPDH) or PTB (pPTB) or the
frameshift variants of each (pfsGAPDH or pfsPTB). These results are
shown in Fig. 6.
|
Stem-loop IIIa of the cell culture-adapted IRES has reduced affinity for GAPDH but not PTB. The mutations in the 5'NTR of HAV that were selected during the adaptation of the wt HM175 virus to growth in African green monkey kidney cells include two changes within segments of the IRES that bind GAPDH (6, 24, 36). Both the deletion of two U residues (nt 203 and 204) from stem-loop IIIa and the U-to-G substitution at nt 687 within stem-loop V result in enhanced activity of the HM175/P16 virus IRES in BSC-1 cells (37). It is notable that both of these translation-enhancing mutations result in the loss of U residues from RNA structures that bind GAPDH, since GAPDH binds preferentially to U-rich RNA sequences (30, 36). Furthermore, as shown in Fig. 5A, overexpression of GAPDH had a less suppressive effect on the HM175/P16 IRES than on the wt IRES in BSC-1 cells. These observations led us to consider the possibility that these mutations might enhance IRES activity by reducing the affinity of the viral RNA for GAPDH, since this would prevent GAPDH-mediated destabilization of secondary RNA structure and preserve IRES function (36). Such a hypothesis is particularly attractive for the mutation in stem-loop IIIa, since the deletion of the two unpaired U residues occurred within a string of five consecutive U residues in the wt sequence (24).
To test this hypothesis, we studied the GAPDH binding activities of the stem-loop IIIa RNA sequences of both the wt and HM175/P16 virus IRES elements in filter binding assays (Fig. 7A). These results confirmed that GAPDH has a lower affinity for the stem-loop IIIa RNA of the cell culture-adapted HM175/P16 virus than for the comparable wt IIIa RNA probe. The binding isotherms obtained in these studies indicated a kd of 1.86 × 10
10 for the wt
RNA probe compared with a kd of 2.35 × 10
10 for the HM175/P16 stem-loop IIIa probe, assuming
that GAPDH exists and binds these RNAs in its tetramer form.
|
10 for
the wt RNA and 1.87 × 10
10 for the HM175/P16 probe,
assuming that PTB exists as a dimer (33) (Fig. 7B). These
results are consistent with those of previous competitive UV
cross-linking studies that suggested that PTB has a higher affinity
than GAPDH for the HM175/P16 virus stem-loop IIIa RNA (36).
However, the results shown in Fig. 7 indicate that PTB and GAPDH have
comparable affinities for the wt stem loop IIIa RNA. The filter binding
results were reproducible in separate experiments.
| |
DISCUSSION |
|---|
|
|
|---|
HAV is highly hepatotropic and replicates poorly in all types of cultured cells. However, during repeated passage, wt virus becomes progressively adapted to replication in cultured African green monkey kidney cells. This process is multifactorial and results in the accumulation within the nonstructural P2 proteins of the virus of mutations that are likely to contribute to viral replicase activity (13, 24). In addition, other mutations accumulate within the viral IRES that facilitate cap-independent translation in a cell-type-specific fashion, reflecting differences that exist between the intracellular environment of these cells and within hepatocytes in situ (37). The experiments described in this report focus on this second aspect of cell culture adaptation and attempt to address the molecular basis for the enhanced translational activity associated with these IRES mutations in African green monkey kidney cells.
The cell-type-specific changes in IRES activity that accompany such mutations are likely to be due to differences in RNA binding proteins that are present in the cytoplasmic compartment of these cells and serve as noncanonical translation initiation factors. Consistent with this hypothesis, there are marked qualitative differences in the RNA binding proteins present in RSW preparations made from African green monkey kidney cells and other cultured cell types (6). A ~39-kDa protein, subsequently identified as GAPDH, was the predominant protein cross-linking to RNA segments within the HAV IRES in RSW from BSC-1 and FRhK-4 cells, while a ~57-kDa protein doublet, identified as PTB, was predominant in RSW prepared from HeLa and Huh-7 cells (6; Chang et al., unpublished). GAPDH and PTB compete for binding to overlapping sites on stem-loop IIIa of the viral RNA, the 5'-most RNA structure within the IRES (36).
PTB facilitates translation directed by picornavirus IRES elements in rabbit reticulocyte lysates in vitro (22, 25, 26). In addition, we have recently demonstrated that the overexpression of PTB stimulates translation directed by IRES elements derived from HAV, poliovirus, and even hepatitis C virus in several different types of cells (17). These IRES elements have little if any common secondary or tertiary RNA structure, and so these results suggest that PTB may act to stabilize RNA structure in a nonspecific fashion and that it may function as a general RNA-folding chaperone (17, 25). GAPDH, on the other hand, appears to have an opposite effect on RNA structure. We previously demonstrated changes in the circular dichroism spectra of stem-loop IIIa RNA, following the binding of GAPDH to this RNA, that are indicative of a melting of the secondary structure of the stem-loop formed by this probe (36). We predicted from these results that GAPDH would have a suppressive effect on IRES-directed translation, a hypothesis that is supported by the results of the studies reported here. Thus, GAPDH and PTB have opposing effects on both higher-order RNA structure and IRES-directed translation. GAPDH suppresses translation by destabilizing essential secondary RNA structures within the IRES, while PTB may reverse this effect by stabilizing structures or by effectively competing with GAPDH for the overlapping sites on the IRES to which these proteins bind.
GAPDH is an abundant protein that is located mainly but not exclusively within the cytoplasm of cells. It is essential for glycolysis, but recent evidence suggests it may have several other important cellular functions (39). GAPDH has RNA binding properties and binds to the untranslated RNA sequences of several different viruses, including human parainfluenza virus type 3, hepatitis B virus, and hepatitis C virus, as well as HAV (12, 34, 45). The data presented here are the first to address the functional consequences of the interaction of GAPDH with any of these viral RNAs. Such studies are complicated by the ubiquitous nature and relatively high abundance of GAPDH. However, the use of dicistronic constructs encoding GAPDH within the upstream reading frame (Fig. 1) is likely to have succeeded because of the ability of these transcripts to increase the GAPDH abundance within the microenvironment of an IRES placed immediately 3' of the GAPDH-coding sequence. This notion is consistent with the fact that there was no detectable increase in the total cellular abundance of GAPDH in cells transfected with these plasmids (Fig. 6A) despite the presence of a significant suppressive effect on IRES function. It also emphasizes the importance of the local concentration of cellular factors such as GAPDH at the site of translation. Although we attempted to assess the impact of GAPDH on HAV translation by cotransfection of the monocistronic GAPDH expression vector (pGAPDH) shown in Fig. 1B and a plasmid encoding a reporter protein under control of the IRES, GAPDH overexpression did not influence IRES-directed translation under these conditions (data not shown).
The results of the GAPDH filter binding experiments (Fig. 7A) indicate that stem-loop IIIa of the cell culture-adapted HM175/P16 viral IRES binds GAPDH with a significantly lower affinity than does the comparable structure in the wt virus. This is consistent with the loss of two uridine residues from a five-residue oligo(U) track that is present at nt 200 to 204 of the wild-type viral RNA, as well as prior observations from our laboratory and others that indicate that GAPDH binds preferentially to U-rich RNA sequences (30, 36). The loss of one or two uridine residues from this oligo(U) track has been noted in at least two independently isolated HAV variants that have been adapted to growth in African green monkey kidney cells, indicating the importance of this mutation to the cell culture adaptation process (8, 24). From a functional perspective, the deletion of the unpaired uridines at nt 203 and 204 results in a significant increase in IRES activity in BSC-1 cells (37). These cells have a relatively low cytoplasmic abundance of PTB (Fig. 6), and GAPDH is the predominant protein in BSC-1 RSW or cytoplasmic extracts that is bound by the viral RNA (6, 37). It is likely that the helix-destabilizing effects of GAPDH would be most evident in a cellular environment with low PTB abundance, due to the ability of PTB to compete with GAPDH for binding to the IRES. In fact, we found GAPDH to have a greater suppressive effect on IRES-directed translation in BSC-1 and FRhK-4 cells than in Huh-7 cells, which have a higher cytoplasmic abundance of PTB (Fig. 5A).
It is intriguing to speculate that the greater activity of HM175/P16 IRES in BSC-1 cells results from a loss of affinity of the viral RNA for GAPDH. This hypothesis is supported by the reduced affinity of the HM175/P16 stem-loop IIIa RNA for GAPDH (Fig. 7) and by the lesser effect of GAPDH overexpression on the HM175/P16 IRES than on the wt IRES in BSC-1 cells (Fig. 5A). The selection of the U-deletion mutation within stem-loop IIIa is also consistent with the greater effect of PTB overexpression on IRES function in BSC-1 cells than in the other cell types studied (Fig. 5B). Notably, PTB overexpression has a lesser translation-enhancing effect in Huh-7 cells (Fig. 5B), presumably because of the greater endogenous cytoplasmic abundance of PTB in this cell type (Fig. 6B) (17). Consistent with this higher PTB abundance, GAPDH overexpression had no demonstrable inhibitory effects on IRES-directed translation in Huh-7 cells and there was no difference in the effect of GAPDH on the wt IRES and on the HM175/P16 IRES in this cell type (Fig. 5A).
While this hypothesis fits the findings with BSC-1 cells particularly well, it does not explain all of the observations with FRhK-4 cells. These cells appear to have a cytoplasmic abundance of PTB comparable to that in BSC-1 cells (Fig. 7B), and, as in BSC-1 cells, GAPDH was the dominant RNA binding protein when RSW from these cells were studied in UV cross-linking experiments (6). Consistent with a similar PTB abundance, GAPDH overexpression had an inhibitory effect on IRES-directed translation that was similar in magnitude to that observed in BSC-1 cells, with a greater inhibition of the wt IRES than of the HM175/P16 IRES (Fig. 5A). Despite this, previous studies indicate that the mutations present in the HM175/P16 IRES (including the deletion of the two uridine residues from stem-loop IIIa) neither enhance IRES-directed translation in these cells nor promote the replication of the virus in this cell type (37). Thus, the translational microenvironment must differ significantly between FRhK-4 and BSC-1 cells, despite similar outcomes in UV-cross-linking studies and apparently similar cellular abundances of both PTB and GAPDH (Fig. 6A). That this is the case is further supported by the relatively low stimulation of IRES-directed translation observed with PTB overexpression (Fig. 5B), which paralleled the results obtained with Huh-7 cells and was strikingly different from the results obtained with BSC-1 cells.
These data are important because they begin to provide a molecular explanation for one aspect of the adaptation of HAV to growth in cell culture, a change in the viral phenotype that is essential for economical production of virus in cell culture for use in vaccine manufacture. Our results indicate that the binding of GAPDH to the viral RNA suppresses cap-independent translation due to destabilization of RNA secondary structure. They further suggest that variations in the local abundance of PTB within the microenvironment of the IRES modulate the negative effects of GAPDH on the viral translational machinery. However, previous UV-cross-linking studies demonstrated that additional, as yet unidentified proteins of ~110 and ~30 kDa also bind viral RNA segments that have affinity for PTB and GAPDH (6). Although these unidentified proteins appear to be universally present in different cell types, their relative abundance and the functional impact of their binding to the viral RNA, if any, are not known. It will be extraordinarily difficult to dissect the complex interplay of these factors with the viral IRES in experiments carried out with cell-free systems in which the microenvironment of the IRES is radically changed. Future studies will need to examine the impact of these proteins on IRES function within specific intracellular environments.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the National Institute of Allergy and Infectious Diseases (RO1-AI32599) and the Advanced Technology Program of the Texas Higher Education Coordinating Board.
We are grateful to Mariano A. Garcia-Blanco for providing the pGST-PTB plasmid and David V. Sangar for his critical review of the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, The University of Texas Medical Branch at Galveston, 301 University Blvd., Galveston, TX 77555-1019. Phone: (409) 772-2354. Fax: (409) 772-3757. E-mail: smlemon{at}utmb.edu.
Present address: Qiagen, Inc., Valencia, CA 91355.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Binn, L. N.,
S. M. Lemon,
R. H. Marchwicki,
R. R. Redfield,
N. L. Gates, and W. H. Bancroft.
1984.
Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures.
J. Clin. Microbiol.
20:28-33 |
| 2. | Blyn, L. B., J. S. Towner, B. L. Semler, and E. Ehrenfeld. 1997. Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J. Virol. 71:6243-6246[Abstract]. |
| 3. |
Borman, A.,
M. T. Howell,
J. G. Patton, and R. J. Jackson.
1993.
The involvement of a spliceosome component in internal initiation of human rhinovirus RNA translation.
J. Gen. Virol.
74:1775-1788 |
| 4. | Borovjagin, A., T. Pestova, and I. Shatsky. 1994. Pyrimidine tract binding protein strongly stimulates in vitro encephalomyocarditis virus RNA translation at the level of preinitiation complex formation. FEBS Lett. 351:299-302[CrossRef][Medline]. |
| 5. |
Brown, E. A.,
S. P. Day,
R. W. Jansen, and S. M. Lemon.
1991.
The 5' nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro.
J. Virol.
65:5828-5838 |
| 6. |
Chang, K. H.,
E. A. Brown, and S. M. Lemon.
1993.
Cell type-specific proteins which interact with the 5' nontranslated region of hepatitis A virus RNA.
J. Virol.
67:6716-6725 |
| 7. |
Cohen, J. I.,
B. Rosenblum,
S. M. Feinstone,
J. Ticehurst, and R. H. Purcell.
1989.
Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA.
J. Virol.
63:5364-5370 |
| 8. |
Cohen, J. I.,
B. Rosenblum,
J. R. Ticehurst,
R. J. Daemer,
S. M. Feinstone, and R. H. Purcell.
1987.
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus.
Proc. Natl. Acad. Sci. USA
84:2497-2501 |
| 9. |
Daemer, R. J.,
S. M. Feinstone,
I. D. Gust, and R. H. Purcell.
1981.
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage.
Infect. Immun.
32:388-393 |
| 10. | Day, S. P., and S. M. Lemon. 1990. A single base mutation in the 5' noncoding region of HAV enhances replication of virus in vitro, p. 175-178. In F. Brown, R. M. Chanock, H. S. Ginsberg, and R. A. Lerner (ed.), Vaccines 90: modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 11. |
Day, S. P.,
P. Murphy,
E. A. Brown, and S. M. Lemon.
1992.
Mutations within the 5' nontranslated region of hepatitis A virus RNA which enhance replication in BS-C-1 cells.
J. Virol.
66:6533-6540 |
| 12. |
De, B. P.,
S. Gupta,
H. Zhao,
J. A. Drazba, and A. K. Banerjee.
1996.
Specific interaction in vitro and in vivo of glyceraldehyde-3-phosphate dehydrogenase and LA protein with cis-acting RNAs of human parainfluenza virus type 3.
J. Biol. Chem.
271:24728-24735 |
| 13. | Emerson, S. U., Y. K. Huang, and R. H. Purcell. 1993. 2B and 2C mutations are essential but mutations throughout the genome of HAV contribute to adaptation to cell culture. Virology 194:475-480[CrossRef][Medline]. |
| 14. |
Emerson, S. U.,
M. Lewis,
S. Govindarajan,
M. Shapiro,
T. Moskal, and R. H. Purcell.
1992.
cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets.
J. Virol.
66:6649-6654 |
| 15. |
Emerson, S. U.,
C. McRill,
B. Rosenblum,
S. Feinstone, and R. H. Purcell.
1991.
Mutations responsible for adaptation of hepatitis A virus to efficient growth in cell culture.
J. Virol.
65:4882-4886 |
| 16. |
Ghetti, A.,
S. Pinol-Roma,
W. M. Michael,
C. Morandi, and G. Dreyfuss.
1992.
hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs.
Nucleic Acids Res.
20:3671-3678 |
| 17. |
Gosert, R.,
K. H. Chang,
R. Rijnbrand,
M. K. Yi,
D. V. Sangar, and S. M. Lemon.
2000.
Transient overexpression of cellular polypyrimidine tract-binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites in vivo.
Mol. Cell. Biol.
20:1583-1595 |
| 18. |
Graff, J.,
A. Normann,
S. M. Feinstone, and B. Flehmig.
1994.
Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants.
J. Virol.
68:548-554 |
| 19. | Gregersen, J. P., S. Mehdi, and R. Mauler. 1988. Adaptation of hepatitis A virus to high titre growth in diploid and permanent cell cultures. Med. Microbiol. Immunol. 177:91-100[Medline]. |
| 20. |
Hellen, C. U.,
G. W. Witherell,
M. Schmid,
S. H. Shin,
T. V. Pestova,
A. Gil, and E. Wimmer.
1993.
A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein.
Proc. Natl. Acad. Sci. USA
90:7642-7646 |
| 21. | Honda, M., S. Kaneko, E. Matsushita, K. Kobayashi, G. Abell, and S. M. Lemon. 2000. Cell cycle regulation of hepatitis C virus IRES-directed translation. Gastroenterology 118:152-162[CrossRef][Medline]. |
| 22. | Hunt, S. L., and R. J. Jackson. 1999. Polypyrimidine-tract binding protein (PTB) is necessary, but not sufficient, for efficient internal initiation of translation of human rhinovirus-2 RNA. RNA 5:344-359[Abstract]. |
| 23. |
Jang, S. K.,
H.-G. Krausslich,
M. J. H. Nicklin,
G. M. Duke,
A. C. Palmenberg, and E. C. Wimmer.
1988.
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.
J. Virol.
62:2636-2643 |
| 24. | Jansen, R. W., J. E. Newbold, and S. M. Lemon. 1988. Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication. Virology 163:299-307[CrossRef][Medline]. |
| 25. | Kaminski, A., S. L. Hunt, J. G. Patton, and R. J. Jackson. 1995. Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA 1:924-938[Abstract]. |
| 26. | Kaminski, A., and R. J. Jackson. 1998. The polypyrimidine tract binding protein (PTB) requirement for internal initiation of translation of cardiovirus RNAs is conditional rather than absolute. RNA 4:626-638[Abstract]. |
| 27. | Lemon, S. M., and B. H. Robertson. 1993. Current perspectives in the virology and molecular biology of hepatitis A virus. Semin. Virol. 4:285-295. |
| 28. |
Meerovitch, K.,
Y. V. Svitkin,
H. S. Lee,
F. Lejbkowicz,
D. J. Kenan,
E. K. Chan,
V. I. Agol,
J. D. Keene, and N. Sonenberg.
1993.
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate.
J. Virol.
67:3798-3807 |
| 29. | Midthun, K., E. Ellerbeck, K. Gershman, G. Calandra, D. Krah, M. McCaughtry, D. Nalin, and P. Provost. 1991. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers. J. Infect. Dis. 163:735-739[Medline]. |
| 30. |
Nagy, E., and W. F. Rigby.
1995.
Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold).
J. Biol. Chem.
270:2755-2763 |
| 31. | Niepmann, M., A. Petersen, K. Meyer, and E. Beck. 1997. Functional involvement of polypyrimidine tract-binding protein in translation initiation complexes with the internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 71:8330-8339[Abstract]. |
| 32. | Pelletier, J., and N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325[CrossRef][Medline]. |
| 33. | Perez, I., J. G. McAfee, and J. G. Patton. 1997. Multiple RRMs contribute to RNA binding specificity and affinity for polypyrimidine tract binding protein. Biochemistry 36:11881-11890[CrossRef][Medline]. |
| 34. |
Petrik, J.,
H. Parker, and G. J. Alexander.
1999.
Human hepatic glyceraldehyde-3-phosphate dehydrogenase binds to the poly(U) tract of the 3' non-coding region of hepatitis C virus genomic RNA.
J. Gen. Virol.
80:3109-3113 |
| 35. | Provost, P. J., and M. R. Hilleman. 1979. Propagation of human hepatitis A virus in cell culture in vitro. Proc. Soc. Exp. Biol. Med. 160:213-221[Medline]. |
| 36. |
Schultz, D. E.,
C. C. Hardin, and S. M. Lemon.
1996.
Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus.
J. Biol. Chem.
271:14134-14142 |
| 37. | Schultz, D. E., M. Honda, L. E. Whetter, K. L. McKnight, and S. M. Lemon. 1996. Mutations within the 5' nontranslated RNA of cell culture-adapted hepatitis A virus which enhance cap-independent translation in cultured African green monkey kidney cells. J. Virol. 70:1041-1049[Abstract]. |
| 38. |
Singh, R., and M. R. Green.
1993.
Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase.
Science
259:365-368 |
| 39. | Sirover, M. A. 1997. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J. Cell. Biochem. 66:133-140[CrossRef][Medline]. |
| 40. | Sjogren, M. H., R. H. Purcell, K. McKee, L. Binn, P. MacArthy, J. Ticehurst, S. Feinstone, J. Caudill, A. See, C. Hoke, W. Bancroft, and E. D'Hondt. 1992. Clinical and laboratory observations following oral or intramuscular administration of a live, attenuated hepatitis A vaccine candidate. Vaccine 10(Suppl. 1):S135-S137. |
| 41. | Stark, M. J. 1987. Multicopy expression vectors carrying the lac repressor gene for regulated high-level expression of genes in Escherichia coli. Gene 51:255-267[CrossRef][Medline]. |
| 42. | Taylor, K. L., P. C. Murphy, L. V. Asher, J. W. LeDuc, and S. M. Lemon. 1993. Attenuation phenotype of a cell culture-adapted variant of hepatitis A virus (HM175/p16) in susceptible New World owl monkeys. J. Infect. Dis. 168:592-601[Medline]. |
| 43. | Weeks, K. M., and T. R. Cech. 1995. Efficient protein-facilitated splicing of the yeast mitochondrial bl5 intron. Biochemistry 34:7728-7738[CrossRef][Medline]. |
| 44. |
Wong, I., and T. M. Lohman.
1993.
A double-filter method for nitrocellulose-filter binding: application to protein-nucleic acid interactions.
Proc. Natl. Acad. Sci. USA
90:5428-5432 |
| 45. | Zang, W. Q., A. M. Fieno, R. A. Grant, and T. S. Yen. 1998. Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranscriptional regulatory element. Virology 248:46-52[CrossRef][Medline]. |
This article has been cited by other articles: